Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

854.56
+25.143.03%
Volume:1.32M
Turnover:1.11B
Market Cap:810.11B
PE:72.98
High:855.50
Open:833.28
Low:829.21
Close:829.42
Loading ...

Eli Lilly (LLY) Gains As Market Dips: What You Should Know

Zacks
·
16 Apr

European pharma companies issue demands to stay in EU ahead of expected US tariffs

Reuters
·
16 Apr

Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy for Long Term Growth?

Insider Monkey
·
16 Apr

Pfizer Halts Obesity Pill Development Amid Safety Concerns

Zacks
·
16 Apr

VERV Stock Soars on Superior Efficacy in Phase I Cholesterol Study

Zacks
·
16 Apr

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

Zacks
·
15 Apr

Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke

TipRanks
·
15 Apr

Eli Lilly and Company (LLY): One of the High Growth Forever Dividend Stocks to Invest In

Insider Monkey
·
15 Apr

Skye Bioscience Demonstrates Over 30% Weight Loss With Nimacimab and Tirzepatide Combination in Preclinical Model

THOMSON REUTERS
·
15 Apr

Skye Bioscience Inc - Nimacimab Phase 2a Top-Line Data Expected Late Q3/Early Q4 2025

THOMSON REUTERS
·
15 Apr

Skye Bioscience Inc - Nimacimab Shows Additive Weight Loss Effect With Tirzepatide in Dio Model

THOMSON REUTERS
·
15 Apr

Market Chatter: China's New Tariffs to Affect US-Made Drugs, Increase Costs

MT Newswires Live
·
15 Apr

Eli Lilly slams PBS as Trump says pharma tariffs not far off

The Australian Financial Review
·
15 Apr

US Begins Probes into Pharmaceutical, Chip Imports, Setting Stage for Tariffs

Reuters
·
15 Apr

Eli Lilly's Mounjaro launch in India ignites wave of weight-loss enquiries

Reuters
·
15 Apr

Eli Lilly (LLY) Stock Jumps as Rival Pfizer Drops Out of Race to Develop Weight Loss Pill

TIPRANKS
·
15 Apr

Pharmaceutical Stocks Trim Their Gains. Trump Says Pharmaceutical Tariffs in Not Too Distant Future

Tiger Newspress
·
15 Apr

Pfizer just had a big setback in its race for an Ozempic competitor

Quartz
·
14 Apr

Eli Lilly Is Maintained at Buy by Guggenheim

Dow Jones
·
14 Apr

Pfizer discontinues GLP-1 pill trial, stock trades flat

Yahoo Finance
·
14 Apr